HealthBanks Biomedical, a new start-up company that was spin off from HealthBanks Biotechnology in April 2020. It becomes a High-Tek Group (TWO3202) in October, 2020. Integration of High-Tek Group resources by our global connections, HealthBanks Biomedical also conduct independent research and specialized innovation of new products, technologies, and applications.
We are the pioneer of Umbilical Cord Tissue Cryopreservation (patented UCT Technology) which was introduced via AABB journal in 2016. We have successfully developed UCT III Plus Technology which preserved therapeutic properties of MSCs, and vascular cells. Except for our outstanding tissue & cell banking technologies, we also developed unique 3D cell culture system for exosome production, and work with physicians on clinical applications.